Reaction

Compartment Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,573 reports · 64 co-occurring drugs

As of the last recalculation, Compartment Syndrome appears in 2,573 FAERS reports alongside 64 co-occurring drug terms. The strongest observed disproportionality signal is NOREPINEPHRINE BITARTRATE (PRR 35.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Norepinephrine Bitartrate	62	35.7	35.8
Norepinephrine	45	34.6	34.8
Fondaparinux Sodium	29	29.3	29.4
Amphetamine	28	27.7	27.8
Alteplase	39	21.3	21.4
Heparin Sodium	32	19.0	19.1
Sevoflurane	19	18.6	18.7
Quinine	19	18.0	18.1
Dalteparin Sodium	21	16.2	16.2
Atropine Sulfate	21	15.8	15.9
Atropine	13	12.8	12.8
Enoxaparin Sodium	86	12.5	12.5
Telmisartan	23	10.5	10.5
Dextrose	16	9.9	9.9
Dextrose Monohydrate	16	9.7	9.7
Warfarin Sodium	53	9.4	9.4
Oseltamivir	9	9.2	9.2
Thiamine Hydrochloride	14	9.1	9.2
Warfarin	136	9.1	9.1
Diphenhydramine	69	9.0	9.1
Adrenalinum	45	8.9	8.9
Methadone	43	8.2	8.3
Derma Foam Excel Hand Sanitizer	8	8.1	8.1
Ethanol	8	8.1	8.1
Calcium Gluconate	12	8.1	8.1
Rocuronium Bromide	11	7.6	7.6
Bupivacaine	8	6.9	6.9
Ethyl Alcohol	22	6.6	6.6
Diphenhydramine Hcl	9	6.6	6.6
Epinephrine	52	6.5	6.5
Tranexamic Acid	7	6.4	6.4
Paroxetine Hydrochloride Hemihydrate	26	6.4	6.4
Alcohol	30	6.3	6.3
Paroxetine	26	6.2	6.2
Cefazolin	7	6.2	6.2
Lithium Carbonate	13	6.2	6.2
Methadone Hydrochloride	8	6.0	6.0
Olanzapine	77	5.9	5.9
Fentanyl Citrate	13	5.9	5.9
Iohexol	6	5.9	5.9
Propofol	26	5.8	5.8
Clopidogrel Bisulfate	69	5.6	5.6
Nifedipine	32	5.5	5.5
Cefazolin Sodium	8	5.4	5.4
Bupropion	29	5.3	5.3
Isopropyl Alcohol	22	5.3	5.3
Sildenafil Powder,	23	5.3	5.3
Glimepiride	25	5.2	5.2
Rivaroxaban	128	5.2	5.2
Midazolam	16	5.2	5.2
Oxazepam	13	4.9	4.9
Buprenorphine	54	4.8	4.8
Emicizumab	7	4.6	4.6
Meropenem	18	4.6	4.6
Linagliptin	10	4.4	4.5
Oxycodone	96	4.3	4.3
Iron Sucrose	5	4.2	4.3
Risperidone	59	3.7	3.7
Dapagliflozin	14	3.6	3.6
Oseltamivir Phosphate	10	3.3	3.3
Dronedarone	4	3.2	3.2
Daptomycin	3	2.6	2.6
Dabigatran Etexilate Mesylate	23	2.6	2.6
Atezolizumab	11	2.3	2.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.